expressTEC

ExpressTec is a biotech startup company founded by two women and a spin-off from the University of Algarve. Our vision is to provide patients with easy access to accurate personalized cancer therapy. To achieve this, we are developing RNA-based approaches to revolutionize clinical testing by accurately and efficiently selecting cancer patients for targeted therapies. Our innovative approach will help to optimize treatment outcomes, reduce side effects, and ultimately improve the quality of life for cancer patients. Join us on our mission to transform cancer care through cutting-edge technology and a commitment to patient-centred solutions. For more information, please visit our website at www.expresstec.pt.